DD133632A5 - Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss-praeparates - Google Patents

Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss-praeparates

Info

Publication number
DD133632A5
DD133632A5 DD7800203381A DD20338178A DD133632A5 DD 133632 A5 DD133632 A5 DD 133632A5 DD 7800203381 A DD7800203381 A DD 7800203381A DD 20338178 A DD20338178 A DD 20338178A DD 133632 A5 DD133632 A5 DD 133632A5
Authority
DD
German Democratic Republic
Prior art keywords
serumewhite
intravenoes
preparates
preparing
applicable
Prior art date
Application number
DD7800203381A
Other languages
English (en)
Inventor
Markus Radowitz
Original Assignee
Plasmesco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0185977A external-priority patent/AT367297B/de
Application filed by Plasmesco Ag filed Critical Plasmesco Ag
Publication of DD133632A5 publication Critical patent/DD133632A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DD7800203381A 1977-01-26 1978-01-24 Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss-praeparates DD133632A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH93477 1977-01-26
AT0185977A AT367297B (de) 1977-03-17 1977-03-17 Verfahren zur herstellung eines serumeiweiss-pr[parates

Publications (1)

Publication Number Publication Date
DD133632A5 true DD133632A5 (de) 1979-01-17

Family

ID=25597003

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7800203381A DD133632A5 (de) 1977-01-26 1978-01-24 Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss-praeparates

Country Status (23)

Country Link
US (1) US4216205A (de)
JP (1) JPS5396315A (de)
AR (1) AR220328A1 (de)
AU (1) AU522413B2 (de)
BE (1) BE863278A (de)
DD (1) DD133632A5 (de)
DE (1) DE2801123C2 (de)
DK (1) DK152334C (de)
EG (1) EG13119A (de)
ES (1) ES466385A1 (de)
FI (1) FI63673C (de)
FR (1) FR2378524A1 (de)
GB (1) GB1597204A (de)
HU (1) HU182554B (de)
IE (1) IE46304B1 (de)
IL (1) IL53856A (de)
IN (1) IN147713B (de)
NL (1) NL7800606A (de)
PL (1) PL124730B1 (de)
SE (1) SE447204B (de)
SU (1) SU786854A3 (de)
YU (1) YU16578A (de)
ZA (1) ZA78295B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492269A2 (fr) * 1980-01-10 1982-04-23 Ionics Appareil d'electrodialyse et procede de fractionnement de melanges de proteines
US4322275A (en) * 1980-01-10 1982-03-30 Ionics Incorporated Fractionation of protein mixtures
US4321192A (en) * 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
US4351710A (en) * 1980-01-10 1982-09-28 Ionics, Incorporated Fractionation of protein mixtures
EP0072843A1 (de) * 1981-02-18 1983-03-02 University Patents, Inc. Niederschlag von proteinen
US4452893A (en) * 1981-08-03 1984-06-05 Cutter Laboratories, Inc. Cell growth medium supplement
US4391801A (en) * 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
DE3245591C2 (de) * 1982-12-09 1986-11-06 Schott Glaswerke, 6500 Mainz Verfahren zur fraktionierten Auftrennung von Stoffgemischen mit Membranen
US4486282A (en) * 1983-02-22 1984-12-04 University Patents, Inc. Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
CN1055095C (zh) * 1992-12-11 2000-08-02 上海莱士血制品有限公司 白蛋白的纯化方法
PT701455E (pt) 1993-06-04 2001-09-27 Biotime Inc Solucao semelhante a plasma
US6680305B1 (en) 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6300322B1 (en) 1993-06-04 2001-10-09 Biotime, Inc. Plasma-like solution
US6627393B2 (en) 1993-06-04 2003-09-30 Biotime, Inc. Solutions for use as plasma expanders and substitutes
US5945272A (en) 1993-06-04 1999-08-31 Biotime, Incorporated Plasma expanders and blood substitutes
US6218099B1 (en) 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US6589223B1 (en) 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6441144B1 (en) * 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
US6596262B2 (en) * 2001-02-15 2003-07-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6806355B2 (en) * 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
CA2742994A1 (en) * 2008-11-12 2010-05-20 Baxter International Inc. Purification of butyrylcholinesterase using membrane adsorption
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
CN110054685A (zh) * 2019-04-26 2019-07-26 兰州兰生血液制品有限公司 一种静注人免疫球蛋白(pH4)低温乙醇组分Ⅲ的生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1207477A (en) * 1969-04-29 1970-10-07 Ts I Gematologii I Perelivania Plasma proteins solution
US3770631A (en) * 1971-06-29 1973-11-06 Baxter Laboratories Inc Clarification of blood serum and plasma
JPS5620287B2 (de) * 1972-06-19 1981-05-13
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3850903A (en) * 1973-06-21 1974-11-26 S Mankarious Plasma volume expander prepared from cohn iv precipitate using block copolymers of ethylene oxide and polyoxypropylene
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen

Also Published As

Publication number Publication date
DK35478A (da) 1978-07-27
BE863278A (nl) 1978-05-16
JPS6241211B2 (de) 1987-09-02
IN147713B (de) 1980-06-07
EG13119A (en) 1981-03-31
JPS5396315A (en) 1978-08-23
IE780088L (en) 1978-07-26
SE7800443L (sv) 1978-07-27
ZA78295B (en) 1978-12-27
YU16578A (en) 1983-10-31
SE447204B (sv) 1986-11-03
PL124730B1 (en) 1983-02-28
SU786854A3 (ru) 1980-12-07
FI780212A (fi) 1978-07-27
AR220328A1 (es) 1980-10-31
FR2378524B1 (de) 1983-02-04
US4216205A (en) 1980-08-05
FI63673B (fi) 1983-04-29
FR2378524A1 (fr) 1978-08-25
IE46304B1 (en) 1983-04-20
DE2801123A1 (de) 1978-07-27
AU522413B2 (en) 1982-06-03
DK152334C (da) 1988-07-25
DK152334B (da) 1988-02-22
DE2801123C2 (de) 1986-01-02
NL7800606A (nl) 1978-07-28
AU3260078A (en) 1979-07-26
FI63673C (fi) 1983-08-10
GB1597204A (en) 1981-09-03
HU182554B (en) 1984-02-28
IL53856A (en) 1981-03-31
PL204214A1 (pl) 1978-09-25
ES466385A1 (es) 1978-10-01

Similar Documents

Publication Publication Date Title
DD133632A5 (de) Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss-praeparates
DD137107A5 (de) Verfahren zur herstellung von spiro-hydantoinderivaten
DD135445A5 (de) Verfahren zur herstellung eines antibiotischen mittels
DD135380A5 (de) Verfahren zur herstellung von 4-acylamino-phenyl-aethanolaminen
DD135500A5 (de) Verfahren zur herstellung von polyaetheramid-saeuren
DD138904A5 (de) Verfahren zur herstellung von prostanderivaten
DD137710A5 (de) Verfahren zur herstellung neuer 1-acyl-2-cyanaziridine
DD135495A5 (de) Verfahren zur herstellung eines wasserunloeslichen enzympraeparats
DD139256A5 (de) Verfahren zur herstellung von substituierten diaminoanthrachinonen
AT353806B (de) Verfahren zur herstellung eines nicht- hygroskopischen lactulosehaeltigen pulvers
DD131019A5 (de) Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides
ATA268678A (de) Verfahren zur herstellung eines isomalto-oligo- saccaridgemisches
DD137584A5 (de) Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten
DD137360A5 (de) Verfahren zur herstellung neu5r nitrosoharnstoff-derivate
DD134098A5 (de) Verfahren zur herstellung eines 9-hydroxyaethoxymethylguanin-derivats
AT358737B (de) Verfahren zur herstellung eines antihaemophilen mittels
DD134865A5 (de) Verfahren zur herstellung eines alkalihaltigen gluehphosphatduengemittels
ATA449178A (de) Verfahren zur herstellung eines keramischen gegenstandes
DD130657A5 (de) Verfahren zur herstellung eines azetamid-derivates
DD131013A5 (de) Verfahren zur herstellung von alpha-ketocarbonsaeuren(b)
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
DD134517A5 (de) Verfahren zur herstellung von p-nitroso-diphenylhydroxylaminen
DD138774A5 (de) Verfahren zur herstellung neuer piperazinopyrrolobenzodiazepinen
DD133229A1 (de) Verfahren zur beschleunigten selektiven herstellung aliphatischer sekundaerer amine
AT357773B (de) Verfahren zur herstellung eines plattenfoermigen koerpers